美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aardvark Therapeutics

12.94

-0.5450-4.04%

成交量：3.51萬

成交額：46.08萬

市值：2.81億

市盈率：-5.77

高：13.46

開：13.46

低：12.82

收：13.48

52周最高：19.58

52周最低：4.88

股本：2,169.69萬

流通股本：588.80萬

量比：1.21

換手率：0.60%

股息：- -

股息率：- -

每股收益(TTM):-2.2430

每股收益(LYR):-0.7400

淨資產收益率：-48.06%

總資產收益率：-30.81%

市淨率：2.29

市盈率(LYR):-17.48

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Aardvark Therapeutics宣佈向FDA提交併獲IRB批准其主打候選藥物ARD-101的修訂試驗方案，擴大普瑞德-威利綜合徵III期研究受試者資格

BUZZ--美國股票走勢-Invivyd、美國天然氣公司、新紀元能源公司

BUZZ-奧本海默將 Aardvark 評為 "跑贏大盤"，看好其差異化肥胖專營權

Aardvark Therapeutics Inc - 加拿大和英國的臨牀試驗地點已獲得註冊許可

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AARD"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AARD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","market":"US","secType":"STK","nameCN":"Aardvark Therapeutics","latestPrice":12.935,"timestamp":1770738060542,"preClose":13.48,"halted":0,"volume":35112,"delay":0,"changeRate":-0.040430267062314534,"floatShares":5888000,"shares":21696893,"eps":-2.243,"marketStatus":"交易中","change":-0.545,"latestTime":"02-10 10:43:13 EST","open":13.46,"high":13.46,"low":12.82,"amount":460801.882464,"amplitude":0.047478,"askPrice":13.09,"askSize":18,"bidPrice":12.9,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-2.243,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"listingDate":1739509200000,"exchange":"NASDAQ","adjPreClose":13.48,"preHourTrading":{"tag":"盘前","latestPrice":13.4112,"preClose":13.48,"latestTime":"09:20 EST","volume":199,"amount":2688.863722,"timestamp":1770733214418,"change":-0.0688,"changeRate":-0.005104,"amplitude":0.123887},"postHourTrading":{"tag":"盘后","latestPrice":13.48,"preClose":13.48,"latestTime":"16:49 EST","volume":1030,"amount":13893.8018,"timestamp":1770673788712,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.209695,"impliedVol":0.9264,"impliedVolPercentile":0.7857},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","floatShares":5888000,"roa":"-30.81%","roe":"-48.06%","lyrEps":-0.74,"volumeRatio":1.209695,"shares":21696893,"dividePrice":0,"high":13.46,"amplitude":0.047478,"preClose":13.48,"low":12.82,"week52Low":4.88,"pbRate":"2.29","week52High":19.58,"institutionHeld":0,"latestPrice":12.935,"committee":-0.285714,"eps":-2.243,"divideRate":0,"volume":35112,"delay":0,"ttmEps":-2.243,"open":13.46,"prevYearClose":13.125,"prevWeekClose":12.65,"prevMonthClose":12.99,"prevQuarterClose":13.125,"fiveDayClose":12.91,"twentyDayClose":14.84,"sixtyDayClose":10.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AARD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"AARD","fiscalQuarterEnding":"2025/09","expectedEps":-0.82,"name":null,"time":"盤後","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.75},{"market":"US","date":"2025-08-13","symbol":"AARD","fiscalQuarterEnding":"2025/06","expectedEps":-0.52,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-05-14","symbol":"AARD","fiscalQuarterEnding":"2025/03","expectedEps":-0.7,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2025-03-31","symbol":"AARD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AARD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AARD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AARD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AARD","date":"2026-02-09","current":-5.76683,"percent":0.877551,"low":-51.17654,"twenty":-10.761865,"median":-8.010618,"eighty":-6.011177,"high":-4.13394,"avg":-10.887651,"sd":8.988674,"marketCap":275431890},"quantilePoints":[{"date":"2025-02-21","current":-51.17654,"twenty":-46.993414,"median":-42.216938,"eighty":-39.920668,"marketCap":368880503},{"date":"2025-02-28","current":-39.75453,"twenty":-42.139802,"median":-40.229211,"eighty":-39.232381,"marketCap":286550651},{"date":"2025-03-07","current":-28.243517,"twenty":-40.603022,"median":-39.176012,"eighty":-36.900511,"marketCap":203579269},{"date":"2025-03-14","current":-31.091602,"twenty":-40.336014,"median":-37.766803,"eighty":-30.723725,"marketCap":224108270},{"date":"2025-03-21","current":-27.23482,"twenty":-39.944402,"median":-34.681377,"eighty":-29.198812,"marketCap":196308580},{"date":"2025-03-28","current":-26.404128,"twenty":-39.576524,"median":-30.913597,"eighty":-27.946841,"marketCap":190320955},{"date":"2025-04-04","current":-9.026143,"twenty":-39.119644,"median":-30.068072,"eighty":-27.341623,"marketCap":185830236},{"date":"2025-04-11","current":-7.397773,"twenty":-38.751766,"median":-29.400552,"eighty":-17.252871,"marketCap":152305358},{"date":"2025-04-17","current":-7.977371,"twenty":-38.300819,"median":-28.45119,"eighty":-8.603741,"marketCap":164238114},{"date":"2025-04-25","current":-8.66235,"twenty":-37.766803,"median":-27.946841,"eighty":-8.371497,"marketCap":178340462},{"date":"2025-05-02","current":-11.939711,"twenty":-36.900511,"median":-27.412825,"eighty":-8.371497,"marketCap":245814773},{"date":"2025-05-09","current":-11.307423,"twenty":-34.865316,"median":-26.68597,"eighty":-8.46634,"marketCap":232797221},{"date":"2025-05-16","current":-7.114571,"twenty":-32.693651,"median":-13.552046,"eighty":-8.46634,"marketCap":197215912},{"date":"2025-05-23","current":-7.834638,"twenty":-31.0204,"median":-11.823792,"eighty":-8.360959,"marketCap":217176159},{"date":"2025-05-30","current":-8.061615,"twenty":-30.818661,"median":-11.433881,"eighty":-8.172533,"marketCap":223467976},{"date":"2025-06-06","current":-9.353039,"twenty":-30.367714,"median":-11.107198,"eighty":-8.178795,"marketCap":259266244},{"date":"2025-06-13","current":-8.656453,"twenty":-30.076972,"median":-10.833207,"eighty":-8.210998,"marketCap":239956875},{"date":"2025-06-20","current":-9.454788,"twenty":-30.053238,"median":-10.188135,"eighty":-8.218152,"marketCap":262086713},{"date":"2025-06-27","current":-10.84796,"twenty":-29.697227,"median":-10.664596,"eighty":-8.356744,"marketCap":300705451},{"date":"2025-07-03","current":-10.894921,"twenty":-29.459887,"median":-10.613156,"eighty":-8.365174,"marketCap":302007206},{"date":"2025-07-11","current":-9.861782,"twenty":-29.308323,"median":-10.597502,"eighty":-8.375712,"marketCap":273368592},{"date":"2025-07-18","current":-9.360866,"twenty":-28.618005,"median":-10.433139,"eighty":-8.40036,"marketCap":259483203},{"date":"2025-07-25","current":-10.542714,"twenty":-28.285052,"median":-10.45662,"eighty":-8.474871,"marketCap":292244042},{"date":"2025-08-01","current":-9.4,"twenty":-28.006176,"median":-10.433139,"eighty":-8.577715,"marketCap":260567999},{"date":"2025-08-08","current":-9.368693,"twenty":-27.946841,"median":-10.061366,"eighty":-8.607418,"marketCap":259700162},{"date":"2025-08-15","current":-6.668132,"twenty":-27.567096,"median":-9.861782,"eighty":-8.474871,"marketCap":244307015},{"date":"2025-08-22","current":-5.762071,"twenty":-27.424692,"median":-9.803081,"eighty":-8.329026,"marketCap":211110768},{"date":"2025-08-29","current":-5.027748,"twenty":-27.270421,"median":-9.525229,"eighty":-8.145134,"marketCap":184206621},{"date":"2025-09-05","current":-5.027748,"twenty":-27.074615,"median":-9.478268,"eighty":-8.014507,"marketCap":184206621},{"date":"2025-09-12","current":-4.61321,"twenty":-26.629602,"median":-9.396086,"eighty":-7.797069,"marketCap":169018796},{"date":"2025-09-19","current":-6.685898,"twenty":-23.929853,"median":-9.368693,"eighty":-7.515801,"marketCap":244957921},{"date":"2025-09-26","current":-7.503129,"twenty":-17.043362,"median":-9.298251,"eighty":-7.308831,"marketCap":274899634},{"date":"2025-10-03","current":-9.102059,"twenty":-12.821851,"median":-9.210333,"eighty":-7.389343,"marketCap":333481245},{"date":"2025-10-10","current":-9.824539,"twenty":-12.161077,"median":-9.298251,"eighty":-7.460987,"marketCap":359951454},{"date":"2025-10-17","current":-7.876213,"twenty":-12.040618,"median":-9.212156,"eighty":-7.503145,"marketCap":288568676},{"date":"2025-10-24","current":-6.425331,"twenty":-11.978881,"median":-9.149542,"eighty":-7.334887,"marketCap":235411289},{"date":"2025-10-31","current":-6.194375,"twenty":-11.800608,"median":-9.102059,"eighty":-7.096882,"marketCap":226949500},{"date":"2025-11-07","current":-5.844979,"twenty":-11.619352,"median":-9.083015,"eighty":-6.739195,"marketCap":214148333},{"date":"2025-11-14","current":-6.453893,"twenty":-11.527382,"median":-8.978494,"eighty":-6.599437,"marketCap":236457733},{"date":"2025-11-21","current":-4.209833,"twenty":-11.386619,"median":-8.807467,"eighty":-6.451943,"marketCap":205321954},{"date":"2025-11-28","current":-4.455369,"twenty":-11.26527,"median":-8.719067,"eighty":-6.366112,"marketCap":217297254},{"date":"2025-12-05","current":-5.535729,"twenty":-11.176245,"median":-8.71121,"eighty":-6.20385,"marketCap":269988572},{"date":"2025-12-12","current":-6.968768,"twenty":-11.12541,"median":-8.663092,"eighty":-6.182531,"marketCap":339880775},{"date":"2025-12-19","current":-6.111623,"twenty":-11.06083,"median":-8.610671,"eighty":-6.174808,"marketCap":298076093},{"date":"2025-12-26","current":-6.366088,"twenty":-10.989171,"median":-8.599121,"eighty":-6.172233,"marketCap":310486858},{"date":"2026-01-02","current":-5.859391,"twenty":-10.980741,"median":-8.405995,"eighty":-6.111623,"marketCap":285774195},{"date":"2026-01-09","current":-6.477696,"twenty":-10.894921,"median":-8.362013,"eighty":-6.093766,"marketCap":315930176},{"date":"2026-01-16","current":-6.852697,"twenty":-10.894921,"median":-8.218152,"eighty":-6.111623,"marketCap":334219725},{"date":"2026-01-23","current":-6.732161,"twenty":-10.894921,"median":-8.171191,"eighty":-6.111623,"marketCap":328340941},{"date":"2026-01-30","current":-5.959837,"twenty":-10.857352,"median":-8.086731,"eighty":-6.108052,"marketCap":290673181},{"date":"2026-02-06","current":-5.040192,"twenty":-10.779084,"median":-8.030062,"eighty":-6.020346,"marketCap":245820240},{"date":"2026-02-09","current":-5.647336,"twenty":-10.761865,"median":-8.010618,"eighty":-6.011177,"marketCap":275431890}],"updateTime":1770738193264},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AARD\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1193243066","title":"Aardvark Therapeutics宣佈向FDA提交併獲IRB批准其主打候選藥物ARD-101的修訂試驗方案，擴大普瑞德-威利綜合徵III期研究受試者資格","url":"https://stock-news.laohu8.com/highlight/detail?id=1193243066","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193243066?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 21:05","pubTimestamp":1770728724,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics今日宣布，已向美国食品药品监督管理局（FDA）提交了其主打候选药物ARD-101的修订临床试验方案，并已获得机构审查委员会（IRB）的批准。此项修订旨在扩大针对普瑞德-威利综合征（PWS）的III期临床研究的受试者资格范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2593473411","title":"BUZZ--美國股票走勢-Invivyd、美國天然氣公司、新紀元能源公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2593473411","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593473411?lang=zh_tw&edition=fundamental","pubTime":"2025-12-24 00:20","pubTimestamp":1766506822,"startTime":"0","endTime":"0","summary":"标普500指数.SPX上涨0.04%，报6881.36点；纳斯达克综合指数.IXIC下跌0.02%，报23425.18点。nL4N3XT0LJ ** Invivyd Inc IVVD.O:BUZZ - 因制药商开始COVID预防抗体的后期试验而上涨。nL4N3XT0M7 ** Freeport-McMoRan Inc FCX.N:BUZZ - 富国银行上调 Freeport-McMoRan PT，因铜业前景光明；股价上涨 nL6N3XT0JK ** Aardvark Therapeutics Inc AARD.O:BUZZ - 奥本海默将 Aardvark 评为 \"跑赢大盘\"，看好其差异化肥胖专营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nL4T3XT0UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH","HL","NUAI","BK4139","IVVD","GILD","EXE","LU2211815571.USD","SGXZ81514606.USD","HIHO","LU0314106906.USD","SPRB","FCX","AFJK","EQT","NOW","CDE","AME","NEM","CNX","LU2168564495.EUR","LU0158827948.USD","IE00B19Z9P08.USD","FSLR","HXHX","SG9999015952.SGD","BK4127","LU0094547139.USD","SOS","LU0154245673.USD","PCLA","BK4141","LU2458330169.SGD","LU1992135472.HKD","LU0654597011.USD","NINE","LU0081259029.USD","SOC","AZO","IE00B1XK9C88.USD","HII","NRDY","LU1223083913.SGD","AARD"],"gpt_icon":1},{"id":"2593349790","title":"BUZZ-奧本海默將 Aardvark 評為 \"跑贏大盤\"，看好其差異化肥胖專營權","url":"https://stock-news.laohu8.com/highlight/detail?id=2593349790","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593349790?lang=zh_tw&edition=fundamental","pubTime":"2025-12-23 20:25","pubTimestamp":1766492743,"startTime":"0","endTime":"0","summary":"BUZZ-奥本海默将 Aardvark 评为 \"跑赢大盘\"，看好其差异化肥胖专营权12月23日 - ** 券商奥本海默给予Aardvark Therapeutics AARD.O\"跑赢大盘 \"评级和35美元的目标价，这意味着该股较上一交易日收盘价有超过两倍的上涨空间。** 奥本海默认为，AARD公司即将推出的治疗PWS的实验性药物ARD-101的后期研究结果是一个重要催化剂，并认为与Soleno Therapeutics公司SLNO.O获得FDA批准的药物Vykat XR相比，ARD-101可能具有更好的安全性。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nL4T3XT0MU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLNO","AARD"],"gpt_icon":0},{"id":"1119474932","title":"Aardvark Therapeutics Inc - 加拿大和英國的臨牀試驗地點已獲得註冊許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1119474932","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119474932?lang=zh_tw&edition=fundamental","pubTime":"2025-12-11 05:24","pubTimestamp":1765401846,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics Inc - 加拿大和英国的临床试验地点已获得注册许可","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AARD\",params:#limit:6,delay:false,,,undefined,":[]}}